Our demonstration of the presence of PD-1 clusters within the tumor microenvironment, combined with the previously demonstrated importance of such clusters in the suppression of T cell activation in cell systems, provides exciting new avenues for research in pathology and immunology. The gene discussed is PDCD1; the disease is neoplasm.